randomized 1
phase 1
iii 1
study 2
abt 1
combination 1
temozolomide 2
recurrent 1
resistant 1
glioblastoma 1
nrg 1
oncology 1
rtog 1
group 1
considerations 1
prophylaxis 1
tumorassociated 1
epilepsy 1
prevention 1
status 1
epilepticus 1
tolerability 1
newer 1
generation 1
aeds 1
